below equally Drake’s and Lynch’s versions, the price of deleterious mutations is what drives mutation fees down (Drake 1991; Lynch 2010; Sung et al. 2012). consequently, less than equally products, an increase in the normal cost of mutations would bring about a lower in mutation charges. To examine this, Drake examined mutation premiums of the